2023

1. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

   Frontiers in Cell and Developmental Biology, Vol. 11

2. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

   Annals of Oncology, Vol. 34, Núm. 10, pp. 920-933